| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1998-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbaa7cae8ac7aceded564d064dbcf9bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c83fa09881000b3e0e01771c64c5a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d43d50f6fcf0862dd742c0e12aefc45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8070c97f4939c855bfff1af58dd530f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c839ebea208e16651d09eb0d8519648 |
| publicationDate |
1999-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H1143500-A |
| titleOfInvention |
Homogeneous monomeric b-amyloid peptide |
| abstract |
(57) [Summary] [Object] To provide a homogeneous monomeric b-amyloid peptide. A method for producing and purifying a homogeneous monomeric b-amyloid peptide, comprising the steps of: a) Formula: ABC (where A is a bulky hydrophilic peptide and B is a selective cleavage site) And C is a b-amyloid peptide or a fusion protein of a b-amyloid peptide having a leucine, serine, glutamine or glutamic acid residue in place of a methionine or methionine sulfoxide residue at position 35). Passing the aqueous solution containing the solution through a hydrophobic matrix column, b) flowing the solution containing the cleavage reagent or enzyme through the column, and c) eluting the resulting b-amyloid peptide with an aqueous water-miscible solvent. How to be. |
| priorityDate |
1993-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |